PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |diabetes |
| Sentences | 529 |
| PubMedID- 23294625 | Several potential new biomarkers for cardiovascular diseases in diabetes have appeared during recent years. |
| PubMedID- 21963020 | Preliminary evidence in support of fruit intake for the prevention of cardiovascular disease in patients with type 2 diabetes mellitus (t2dm) is still limited. |
| PubMedID- 26485682 | Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity [1–4]. |
| PubMedID- 20647285 | Objective: to determine the extent to which intensive dietary intervention can influence glycaemic control and risk factors for cardiovascular disease in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment. |
| PubMedID- 23940992 | Study included 313 normoalbuminuric patients with type 1 diabetes, none showed signs of adrenal, renal, or cardiovascular diseases. |
| PubMedID- 24344928 | Logistic regression was used to estimate the odds ratios of prevalent cardiovascular disease associated with self-reported diabetes, and with measured random blood glucose levels among participants with no history of diabetes, adjusting simultaneously for age, sex, area, education, smoking, alcohol, blood pressure and physical activity. |
| PubMedID- 21911774 | The need to manage the risks for cardiovascular disease associated with type 1 diabetes should be considered from childhood. |
| PubMedID- 22952467 | (b) that insulin resistance is the major determinant of vascular disease in patients with diabetes deserves reconsideration. |
| PubMedID- 23071607 | Background: peripheral vascular disease in pre-diabetes may involve altered sympathetically-mediated vascular control. |
| PubMedID- 24023876 | Activity causing sweating and/or breathlessness), current daily smoking (cigarettes/cigar/pipe), self-reported diabetes and history of cardiovascular disease [cvd] (angina pectoris, myocardial infarction or stroke) were obtained from the questionnaires. |
| PubMedID- 26055067 | This paper describes the relationship of baseline fgf21 levels and new on-study microvascular disease in patients with type 2 diabetes from the field study. |
| PubMedID- 26063568 | Diagnoses of malignancy, diabetes with complications, cerebrovascular disease, as well as acute and chronic renal failure were used to assess additional comorbidity. |
| PubMedID- 24889279 | Smoking, diabetes, metabolic syndrome, history of cardiovascular disease, increased waist circumference, and elevated pre-treatment ldl-c level were all associated with not reaching ldl-c goals. |
| PubMedID- 21390057 | Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 20860758 | Although data suggest that the control of hyperglycaemia may have a different impact on primary and secondary prevention of cardiovascular disease in patients with type 2 diabetes, in the navigator study, patients in these two groups were pooled and evaluated together (38). |
| PubMedID- 21035578 | There is also strong evidence that blood pressure targets for populations at high risk of cardiovascular disease, including those with diabetes, coronary artery disease, and chronic kidney disease, should be lower than 140/90 mm hg. |
| PubMedID- 21291555 | Apart from the combination of cardiovascular disease with comorbid diabetes reported by 60.2%, arthritis was consistently among the most commonly reported comorbid condition, being reported by a third of people with the index conditions. |
| PubMedID- 22526620 | Poorly managed type 1 diabetes can lead to cardiovascular disease, diabetic neuropathy, and diabetic retinopathy. |
| PubMedID- 22210236 | Objective: depression in type 2 diabetes is associated with obesity, cardiovascular disease, and mortality. |
| PubMedID- 24728837 | The presence of cardiovascular diseases was significantly associated with diabetes mellitus in patients with copd. |
| PubMedID- 20191077 | Proactive trial36 enrolled 5238 patients with type 2 diabetes who had evidence of macrovascular disease in a prospective, randomized study. |
| PubMedID- 23144257 | Hypertension and diabetes are initial stages of cardiovascular disease, and the risk is elevated because of the high prevalence of tobacco smoking among men. |
| PubMedID- 25995772 | In addition, oxldl is an important factor for predicting cardiovascular disease in patients with diabetes [19]. |
| PubMedID- 24227183 | Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the swedish national diabetes register. |
| PubMedID- 23008738 | However, the results varied by population (healthy adults, adults at cardiovascular disease risk, adults with type 2 diabetes, etc.) |
| PubMedID- 23540820 | Screening for peripheral vascular disease in patients with type 2 diabetes in malta in a primary care setting. |
| PubMedID- 26516107 | The aim of this study was to analyse all-cause mortality and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes detected by screening or diagnosed clinically. |
| PubMedID- 26413719 | Model 2 represents model 1 plus adjustment for body mass index and comorbidities including hypertension, diabetes mellitus and history of cerebrovascular disease. |
| PubMedID- 22111042 | In addition, hypertension, dyslipidemia and associated diseases, various macrovascular diseases associated with diabetes, and a history of complications from vascular disease were verified through surveys. |
| PubMedID- 25391871 | Objective: to explore the change and possible role of blood lipids during the course of plaque formation induced by diabetes mellitus in patients with ischemic cerebral vascular disease. |
| PubMedID- 25903071 | Evidence for an excess risk of cardiovascular disease associated with diabetes in women is increasing, an observation that urges intensified treatment and management of female diabetes patients. |
| PubMedID- 22301120 | The outcome of cardiovascular diseases in patients with diabetes is known to be better in the japanese population. |
| PubMedID- 20653327 | Therapeutic potential of aleglitazar, a new dual ppar-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 24705616 | We further investigated the association between diabetes and different phenotypes of vascular disease in women and men (table 2). |
| PubMedID- 24498934 | Ev-markers and the risk of new onset type 2 diabetes in patients with manifest cardiovascular disease. |
| PubMedID- 23978254 | From february 2002 to january 2005, we enrolled 135 consecutive asymptomatic patients (74 male; mean age, 63 ± 9 years) with type 2 diabetes without a history of cardiovascular disease. |
| PubMedID- 21569580 | Previous reports have outlined the prognostic importance of undiagnosed diabetes in patients with different cardiovascular diseases [16,20-22]. |
| PubMedID- 20929996 | Therefore, the aim of our study was to evaluate whether repeated episodes of hypoglycemia represent an aggravating factor for macrovascular disease in subjects with type 1 diabetes through early atherosclerosis-vascular assessment. |
| PubMedID- 25848912 | The association between circulating mmps and macrovascular disease in patients with type 1 diabetes has not been investigated, while studies on the associations between mmp levels and microvascular complications seem contradictory. |
| PubMedID- 22375126 | Participants were excluded if they failed a screening cardiac stress test, had type 1 diabetes, had a history of major cardiovascular disease, had orthopedic or rheumatologic problems that impeded exercise, and/or started or changed cholesterol drug use within the previous 3 months. |
| PubMedID- 26246173 | Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association. |
| PubMedID- 19754853 | Methods: cardiovascular disease patients with diabetes mellitus (group a, n = 14) and nondiabetic patients with cvd only (group b, n = 10) took atorvastatin 80 mg per day for a period of 8-10 weeks. |
| PubMedID- 22936794 | At the time of diagnosis of diabetes, patients with established cardiovascular disease had significantly lower mean levels of blood pressure than those without cardiovascular disease (table 1). |
| PubMedID- 26089876 | Two adjacent regions upstream cdkn2b on chromosome 9p21 have been associated with type 2 diabetes (t2d) and progression of cardiovascular disease (cvd). |
| PubMedID- 23878823 | Atherosclerosis that is often found in type 2 diabetes is a complication of macrovascular disease that increases the risk for myocardial infarction and strokes. |
| PubMedID- 23625211 | In part ii of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. |
| PubMedID- 21470634 | Background: accelerated cardiovascular disease in patients with type i diabetes (tid) is a well-described condition and serious clinical obstacle. |
| PubMedID- 23385371 | While some authorities, primarily those funded by the food industry, have argued that the high amounts of added sugars in food and beverages may contribute to health risks solely as a consequence of their caloric content, there is also mounting evidence that fructose may have a specific ability to cause fatty liver (which can progress to cirrhosis of the liver), high triglycerides in blood (which can contribute to cardiovascular disease), insulin resistance (leading to type 2 diabetes) and increased appetite (which obviously can lead to obesity) [5,6]. |
| PubMedID- 22021772 | The excess risk of vascular disease in persons with diabetes is about twofold compared with those without diabetes and is independent of other conventional cardiovascular risk factors. |
| PubMedID- 23245213 | Background: abnormal circadian blood pressure patterns have been associated with cardiovascular disease in diabetes mellitus. |